Head of AI-Driven Clinical Evidence & Strategy

AstraZeneca; Gaithersburg (MD); Vor Ort; USD 258.000 - 387.000; Vollzeit

Benefits dieser Stelle

401(k) plan

Health benefits

Paid vacation

Zusammenfassung

AstraZeneca plc is seeking an Executive Director to lead AI-enabled evidence capabilities across the product lifecycle, integrating clinical trials, real-world data, and multimodal inputs into continuously learning evidence ecosystems.

You will drive governance, validation frameworks, and external partnerships to ensure evidence assets meet regulatory and payer standards while scaling across health systems and therapies.

Qualifikationen

• Advanced degree in Statistics, Epidemiology, Data Science, Mathematics, or related field.
• 15+ years in biopharma with clinical development and evidence strategy.
• Experience leading global, matrixed teams with enterprise-level influence.
• Proven ability applying AI/advanced analytics to clinical and real-world datasets.
• Strong understanding of regulatory and payer expectations for real-world validation.

Aufgaben

• Define multi-year strategy for AI-enabled evidence across product lifecycle.
• Industrialize AI-enabled methodologies for multimodal clinical and real-world data.
• Establish governance for AI-enabled evidence and foundation models.
• Engage regulators and HTA bodies to advance credible AI-driven evidence methods.
• Lead data partnerships and scalable evidence infrastructures.

Kenntnisse

AI leadership

Regulatory strategy

Cross-functional leadership

Evidence generation

Ausbildung

Advanced degree (PhD/MD/MSc) in relevant field

Jobbeschreibung

AstraZeneca plc is seeking an Executive Director to lead AI-enabled evidence capabilities across the product lifecycle, integrating clinical trials, real-world data, and multimodal inputs into continuously learning evidence ecosystems.

You will drive governance, validation frameworks, and external partnerships to ensure evidence assets meet regulatory and payer standards while scaling across health systems and therapies.